Pharmacogenetic Testing for Prevention of Severe Cutaneous Adverse Drug Reactions

被引：43

作者：

Chang, Chih-Jung ^{[1
,2
,3
,4
,5
,6
]}

Chen, Chun-Bing ^{[1
,2
,3
,4
,5
,6
,7
,8
,9
,10
]}

Hung, Shuen-Iu ^{[1
,2
,3
,4
,7
]}

Ji, Chao ^{[11
]}

Chung, Wen-Hung ^{[1
,2
,3
,4
,5
,6
,7
,8
,9
,12
,13
]}

机构：

[1] Chang Gung Mem Hosp, Dept Dermatol, Taipei, Taiwan

[2] Chang Gung Mem Hosp, Drug Hypersensit Clin & Res Ctr, Taipei, Taiwan

[3] Chang Gung Mem Hosp, Dept Dermatol, Keelung, Taiwan

[4] Chang Gung Mem Hosp, Drug Hypersensit Clin & Res Ctr, Keelung, Taiwan

[5] Huaqiao Univ, Xiamen Chang Gung Hosp, Sch Med, Cent Res Lab,Dept Dermatol, Xiamen, Peoples R China

[6] Huaqiao Univ, Xiamen Chang Gung Hosp, Sch Med, Xiamen Chang Gung Allergol Consortium, Xiamen, Peoples R China

[7] Chang Gung Mem Hosp, Dept Med Res, Canc Vaccine & Immune Cell Therapy Core Lab, Taoyuan, Taiwan

[8] Chang Gung Univ, Coll Med, Taoyuan, Taiwan

[9] Chang Gung Mem Hosp, Whole Genome Res Core Lab Human Dis, Keelung, Taiwan

[10] Chang Gung Univ, Grad Inst Clin Med Sci, Taoyuan, Taiwan

[11] Fujian Med Univ, Affiliated Hosp 1, Dept Dermatol, Fuzhou, Peoples R China

[12] Tsinghua Univ, Beijing Tsinghua Chang Gung Hosp, Sch Clin Med, Dept Dermatol, Beijing, Peoples R China

[13] Shanghai Jiao Tong Univ, Sch Med, Shanghai, Peoples R China

来源：

FRONTIERS IN PHARMACOLOGY | 2020年 / 11卷

关键词：

drug hypersensitivity; pharmacogenetics; severe cutaneous adverse reactions; human-leukocyte antigen; T cell receptor; STEVENS-JOHNSON-SYNDROME; TOXIC EPIDERMAL NECROLYSIS; COST-EFFECTIVENESS ANALYSIS; HLA CLASS-I; INDUCED LIVER-INJURY; HLA-B-ASTERISK-1502; ALLELE; T-CELLS; HYPERSENSITIVITY REACTIONS; JAPANESE PATIENTS; ALLOPURINOL HYPERSENSITIVITY;

D O I：

10.3389/fphar.2020.00969

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Severe cutaneous adverse reactions (SCAR), such as Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and drug rash with eosinophilia and systemic symptoms (DRESS), are idiosyncratic and unpredictable drug-hypersensitivity reactions with a high-mortality rate ranging from 10% to over 30%, thus causing a major burden on the healthcare system. Recent pharmacogenomic studies have revealed strong associations between SCAR and the genes encoding human-leukocyte antigens (HLAs) or drug-metabolizing enzymes. Some of pharmacogenetic markers have been successfully applied in clinical practice to protect patients from SCAR, such as HLA-B*15:02 and HLA-A*31:01 for new users of carbamazepine, HLA-B*58:01 for allopurinol, and HLA-B*57:01 for abacavir. This article aims to update the current knowledge in the field of pharmacogenomics of drug hypersensitivities or SCAR, and its implementation in the clinical practice.

引用

页数：11

共 108 条

[21] Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis [J].

Chung, Wen-Hung ;

Hung, Shuen-Iu ;

Yang, Jui-Yung ;

Su, Shih-Chi ;

Huang, Shien-Ping ;

Wei, Chun-Yu ;

Chin, See-Wen ;

Chiou, Chien-Chun ;

Chu, Sung-Chao ;

Ho, Hsin-Chun ;

Yang, Chih-Hsun ;

Lu, Chi-Fang ;

Wu, Jer-Yuarn ;

Liao, You-Di ;

Chen, Yuan-Tsong .

NATURE MEDICINE, 2008, 14 (12) :1343-1350

[22] A marker for Stevens-Johnson syndrome [J].

Chung, WH ;

Hung, SI ;

Hong, HS ;

Hsih, MS ;

Yang, LC ;

Ho, HC ;

Wu, JY ;

Chen, YT .

NATURE, 2004, 428 (6982) :486-486

[23] Association between CYP2B6 polymorphisms and Nevirapine-induced SJS']JS/TEN: a pharmacogenetics study [J].

Ciccacci, Cinzia ;

Di Fusco, Davide ;

Marazzi, Maria C. ;

Zimba, Ines ;

Erba, Fulvio ;

Novelli, Giuseppe ;

Palombi, Leonardo ;

Borgiani, Paola ;

Liotta, Giuseppe .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 69 (11) :1909-1916

[24] AAN-EFNS guidelines on trigeminal neuralgia management [J].

Cruccu, G. ;

Gronseth, G. ;

Alksne, J. ;

Argoff, C. ;

Brainin, M. ;

Burchiel, K. ;

Nurmikko, T. ;

Zakrzewska, J. M. .

EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 (10) :1013-1028

[25] HLA-B☆5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin [J].

Daly, Ann K. ;

Donaldson, Peter T. ;

Bhatnagar, Pallav ;

Shen, Yufeng ;

Pe'er, Itsik ;

Floratos, Aris ;

Daly, Mark J. ;

Goldstein, David B. ;

John, Sally ;

Nelson, Matthew R. ;

Graham, Julia ;

Park, B. Kevin ;

Dillon, John F. ;

Bernal, William ;

Cordell, Heather J. ;

Pirmohamed, Munir ;

Aithal, Guruprasad P. ;

Day, Christopher P. .

NATURE GENETICS, 2009, 41 (07) :816-U71

[26] HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in Vietnamese [J].

Dinh Van Nguyen ;

Hieu Chi Chu ;

Doan Van Nguyen ;

Minh Hong Phan ;

Craig, Timothy ;

Baumgart, Karl ;

van Nunen, Sheryl .

ASIA PACIFIC ALLERGY, 2015, 5 (02) :68-77

[27] Human leucocyte antigen class II genotype in susceptibility and resistance to co-amoxiclav-induced liver injury [J].

Donaldson, Peter T. ;

Daly, Ann K. ;

Henderson, Jill ;

Graham, Julia ;

Pirmohamed, Munir ;

Bernal, William ;

Day, Christopher P. ;

Aithal, Guruprasad P. .

JOURNAL OF HEPATOLOGY, 2010, 53 (06) :1049-1053

[28] Carbamazepine, HLA-B*1502 and risk of Stevens-Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations [J].

Ferrell, P. Brent, Jr. ;

McLeod, Howard L. .

PHARMACOGENOMICS, 2008, 9 (10) :1543-1546

[29] HLA-A*31:01 and different types of carbamazepine-induced severe cutaneous adverse reactions: an international study and meta-analysis [J].

Genin, E. ;

Chen, D-P ;

Hung, S-I ;

Sekula, P. ;

Schumacher, M. ;

Chang, P-Y ;

Tsai, S-H ;

Wu, T-L ;

Bellon, T. ;

Tamouza, R. ;

Fortier, C. ;

Toubert, A. ;

Charron, D. ;

Hovnanian, A. ;

Wolkenstein, P. ;

Chung, W-H ;

Mockenhaupt, M. ;

Roujeau, J-C .

PHARMACOGENOMICS JOURNAL, 2014, 14 (03) :281-288

[30] Penicillin allergy: A practical guide for clinicians [J].

Gonzalez-Estrada, Alexei ;

Radojicic, Cristine .

CLEVELAND CLINIC JOURNAL OF MEDICINE, 2015, 82 (05) :295-300

← 1 2 3 4 5 6 7 8 9 10 →